Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-09

Clinical Trial Update: Anesthesia Induction With Intravenous Bolus or Continuous Infusion of Remimazolam [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating anesthesia induction with remimazolam delivered as an IV bolus or continuous infusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remimazolam (remimazolam)

Snippet

Sponsor: Korea University Guro Hospital | Conditions: Adult, Anesthesia, General | Phase 4 | Status: COMPLETED